Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Europe Digital Therapeutics Market Variables, Trends and Scope

  •          1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Europe Digital Therapeutics Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Europe Digital Therapeutics Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Europe Digital Therapeutics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Diabetes
      2. Obesity
      3. Cardiovascular Disease (CVD)
      4. Central Nervous System (CNS) Disease
      5. Respiratory Disease
      6. Smoking Cessation
      7. Gastrointestinal Disorder (GID)
      8. Others

• 8.   Europe Digital Therapeutics Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Software
      2. Device

• 9.   Europe Digital Therapeutics Market, By Sales Channel Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Business-to-Business (B2B)
       1.1. Employer
       1.2. Healthcare Provider
       1.3. Others
      2. Business-to-Consumer (B2C)
       2.1. Patient
       2.2. Caregiver

• 10.   Europe Digital Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 11.   Market Share Analysis and Competitive Landscape
  •   1. Europe Landscape - Key Players, Revenue and Presence
      2. Europe Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Europe Emerging Companies
      4. Europe - Market Share Analysis and Key Regional Players
      5. Europe Key Player - Growth Matrix
    
• 12.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Applications Offered and Financial Layouts)

  •   1. Ada Health GmbH
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. CogniFit
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Caterna Vision GmbH
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Fitbit, Inc. (Twine Health, Inc.)
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Kaia Health
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Medtronic Plc.
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Novartis International AG (Pear Therapeutics, Inc.)
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. ResMed, Inc. (Propeller Health)
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. Sonormed GmbH
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
        10. Voluntis, Inc
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview

• 13.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by
                administrations
      5. The overall economic slowdown of the developing and developed nations

• 14.   FutureWise SME Key Takeaway Points for Client